NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Gradientech

Gradientech

Private
UppsalaHealthcare & Life Scienceshttps://gradientech.se/

Last Round

Private Placement

Mar 26, 2026

Est. Valuation

$51.88M

Total Funding Raised

$1.58M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Gradientech is a diagnostics company that develops and provides a microfluidics-based system for ultra-rapid antibiotic susceptibility testing.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

antibiotic susceptibility testingASTrapid diagnosticssepsis diagnosticsin-vitro diagnosticssepsis testIVDMinimum Inhibitory ConcentrationMICphenotypic ASTantimicrobial resistanceAMRmicrofluidics technologydiagnostic instrumentdiagnostic consumablesclinical microbiologyFDA Breakthrough Device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gradientech Comparables

Compare Gradientech with similar companies based on industry and business-model similarity.

Gradientech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Affinity Biosensors
88%
SeLux Diagnostics
87%
QuantaMatrix Inc.
87%

Gradientech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMar 26, 2026
Private PlacementFeb 5, 2025
Private PlacementSep 24, 2024
Private PlacementJul 4, 2024
Private PlacementNov 13, 2023
Convertible Debt
Jul 12, 2023

Key People

Founding team and executive leadership

Marcus Sunnemar Berglund

CTO

Executive Team

Urban Adolfsson

CFO

Executive Team

Gradientech Investors

Notable investors and investment history

Gradientech investors
InvestorRounds
Almi Invest ABVC Round
CBC Investment GroupPrivate Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    Raised $5.21M in a Rights Issue round.

  • Feb 10, 2026

    Working with FDA to address requested information in ongoing review.

Gradientech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Gradientech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gradientech's valuation, stock price, and market status.

Firmographic Details

HeadquartersUppsala
Employee Range42
Year Founded2009
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.